Senior Clinical Study Manager – Rare Disease, Phase 3 (Hybrid) (Hobart)

Senior Clinical Study Manager – Rare Disease, Phase 3 (Hybrid) (Hobart)

28 Oct
|
Cycle Pharmaceuticals
|
Hobart

28 Oct

Cycle Pharmaceuticals

Hobart

Cycle Pharmaceuticals is seeking a Senior Clinical Study Manager to lead the operational delivery of Phase 3 trials and Phase 4 post-approval studies across rare diseases from feasibility to final report. The role reports to the Associate Director of Clinical Operations and requires oversight of timelines, budgets, quality and regulatory compliance.
You will own studies, coordinate site selection, supply planning, and DMC activities while collaborating with cross-functional teams.
#J-*****-Ljbffr

📌 Senior Clinical Study Manager – Rare Disease, Phase 3 (Hybrid) (Hobart)
🏢 Cycle Pharmaceuticals
📍 Hobart

Reply to this offer

Impress this employer describing Your skills and abilities, fill out the form below and leave Your personal touch in the presentation letter.

Subscribe to this job alert:

Get the latest job offers by email for: senior clinical study manager – rare disease, phase 3 (hybrid) (hobart) / hobart

Subscribe to this job alert:

Get the latest job offers by email for: senior clinical study manager – rare disease, phase 3 (hybrid) (hobart) / hobart